论文部分内容阅读
此组占同期急性白血症的3.0％。急非淋9例,急淋1例,治前白血病浸润及出血倾向较轻,均经诱导治疗获CR。CR的有效化疗方案:COATP3例,COAMP2例,COAP1例,HOAP1例,VNIMP2例,6MP+强地松1例。诱导缓解期WBC均≤1.5×10~9/L,其中9例≤1.0×10~9/L,均有骨髓抑制,提示经过强烈化疗可获CR。大多持续治疗2年以上,8例仍处于首次CR期,1例CR后定期复查骨髓,原+早幼粒在10％左右。2次,
This group accounted for 3.0% of the same period acute leukemia. 9 cases of acute non-leaching, acute leaching in 1 case, pre-treatment leukemia infiltration and bleeding tend to be mild, were induced by treatment of CR. CR effective chemotherapy: COATP3 cases, COAMP2 cases, COAP1 cases, HOAP1 cases, VNIMP2 cases, 6MP + prednisone in 1 case. The WBC in induction remission was ≤1.5 × 10 ~ 9 / L, of which 9 cases ≤1.0 × 10 ~ 9 / L, all with myelosuppression, suggesting that after intensive chemotherapy can be CR. Most of the patients continued treatment for more than 2 years, 8 cases were still in the first CR stage, and 1 case had regular review of bone marrow after CR. The original + promyelocytes were about 10%. 2 times,